| pubmed-article:6155689 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6155689 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:6155689 | lifeskim:mentions | umls-concept:C0026764 | lld:lifeskim |
| pubmed-article:6155689 | lifeskim:mentions | umls-concept:C0024419 | lld:lifeskim |
| pubmed-article:6155689 | lifeskim:mentions | umls-concept:C1518997 | lld:lifeskim |
| pubmed-article:6155689 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:6155689 | pubmed:dateCreated | 1980-8-15 | lld:pubmed |
| pubmed-article:6155689 | pubmed:abstractText | Antisera raised against idiotypic determinants (ID) of myeloma proteins and macroglobulins have been used to differentiate peripheral blood lymphocyte (PBL) populations from individual patients. ID-positive lymphocytes not resembling plasma cells have been regularly found in peripheral blood in these diseases. For further characterization ID-positive lymphocytes were enriched from the peripheral blood by affinity chromatography using heterologous anti-idiotypic sera. Two patients with IgG myeloma, one patient with Waldenström's macroglobulinaemia and two persons with benign monoclonal hyperglobulinaemia (BMH) were examined by this technique. The ID-positive PBL population was shown to be heterogeneous with respect to non-tumour-specific surface markers, such as sheep erythrocytes (SRBC), Fc and C receptors. Tumour-specific idiotypic determinants will thus allow a more correct recognition of the total tumour cell compartment in these diseases. | lld:pubmed |
| pubmed-article:6155689 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6155689 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6155689 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6155689 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6155689 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6155689 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6155689 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6155689 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6155689 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6155689 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6155689 | pubmed:issn | 0300-9475 | lld:pubmed |
| pubmed-article:6155689 | pubmed:author | pubmed-author:EckertGG | lld:pubmed |
| pubmed-article:6155689 | pubmed:author | pubmed-author:DeicherHH | lld:pubmed |
| pubmed-article:6155689 | pubmed:author | pubmed-author:SchedelII | lld:pubmed |
| pubmed-article:6155689 | pubmed:author | pubmed-author:FrickeMM | lld:pubmed |
| pubmed-article:6155689 | pubmed:author | pubmed-author:StünkelKK | lld:pubmed |
| pubmed-article:6155689 | pubmed:author | pubmed-author:PeestDD | lld:pubmed |
| pubmed-article:6155689 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6155689 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:6155689 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6155689 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6155689 | pubmed:pagination | 437-44 | lld:pubmed |
| pubmed-article:6155689 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:meshHeading | pubmed-meshheading:6155689-... | lld:pubmed |
| pubmed-article:6155689 | pubmed:year | 1980 | lld:pubmed |
| pubmed-article:6155689 | pubmed:articleTitle | Idiotype-bearing peripheral blood lymphocytes in human multiple myeloma and Waldenström's macroglobulinaemia. | lld:pubmed |
| pubmed-article:6155689 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6155689 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6155689 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6155689 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6155689 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6155689 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6155689 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6155689 | lld:pubmed |
